Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07228637 · ClinicalTrials.gov registry record · NA
Pursuing Exploration Into the Supportive Care Needs and Intervention Preferences of Survivors of Testicular Cancer
A NA study of Testicular Cancer, sponsored by Indiana University.
- Active
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT07228637 is a NA study of Testicular Cancer that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 70 participants, below the 89-participant average among 11 other Testicular Cancer trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07228637, a NA study of Testicular Cancer, is active but no longer recruiting, sponsored by Indiana University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial tests the impact of an Acceptance and Commitment Therapy (ACT)-based coaching program delivered via videoconferencing on fear of cancer recurrence (primary outcome), anxiety, other symptoms, health-related quality of life, and coping (secondary outcomes) in survivors of testicular cancer. ACT includes experiential training in present moment awareness (e.g., mindfulness meditation, performing activities with greater awareness), coping adaptively with difficult internal experiences (e.g., thoughts, feelings, body sensation), identifying personally meaningful values, and pursuing activities consistent with these values. Testicular cancer survivors (N=70) will be randomly assigned in equal numbers to either an ACT-based coaching program or an education/support coaching program, both delivered via videoconferencing. Survivors in both conditions will participate in six weekly 90-minute online group sessions. Outcomes will be assessed at baseline, 2 weeks post-intervention, and 3 months post-intervention. The investigators hypothesize that ACT will lead to improved primary and secondary outcomes as compared to education/support. Study findings will inform a large-scale trial of intervention efficacy.
Conditions Studied
Interventions
- BEHAVIORAL Acceptance and Commitment Therapy (ACT) Coaching
- BEHAVIORAL Education and Support Coaching
Study Locations (1)
Indiana
- Indiana University - Indianapolis - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-08-18 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07228637
The ClinicalTrials.gov registry entry for NCT07228637 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 89-participant average among 11 other Testicular Cancer trials with a reported enrollment target (21% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Testicular Cancer appearing as the primary indexed condition, and to 2 interventions - of which Acceptance and Commitment Therapy (ACT) Coaching is the first listed.
NCT07228637 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT07228637 about?
NCT07228637 is a clinical study titled "Pursuing Exploration Into the Supportive Care Needs and Intervention Preferences of Survivors of Testicular Cancer". This trial tests the impact of an Acceptance and Commitment Therapy (ACT)-based coaching program delivered via videoconferencing on fear of cancer recurrence (primary outcome), anxiety, other symptoms, health-related quality of life, and coping (secondary outcomes) in survivors of testicular cancer....
What is the current status of trial NCT07228637?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-08-18. Estimated completion is 2026-07-01.
What conditions does trial NCT07228637 study?
This clinical trial studies the following conditions: Testicular Cancer.
What interventions are being tested in trial NCT07228637?
The interventions under investigation include: Acceptance and Commitment Therapy (ACT) Coaching (BEHAVIORAL), Education and Support Coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT07228637?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07228637 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Testicular Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy
RECRUITING · NA
-
A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
RECRUITING · NA
-
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
RECRUITING · NA
-
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
RECRUITING · NA
-
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
RECRUITING · Phase 1
-
Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.